PRPO logo.png
Precipio to distribute HemeScreen® through Fisher Healthcare channel
20 juil. 2022 10h30 HE | Precipio, Inc.
NEW HAVEN, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has entered into an agreement with Fisher Healthcare,...
researchdrivelogo.jpg
Bloodstream Infection Testing Market Expected to Garner $7,722.2 Million in the 2020-2027 Timeframe, Growing at 8.4% CAGR [247-Pages] | Research Dive
13 juin 2022 09h10 HE | Research Dive
New York, USA, June 13, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global bloodstream infection testing market is predicted to rise at a tremendous CAGR...
PRPO logo.png
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
26 avr. 2022 10h00 HE | Precipio, Inc.
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its participation and the presentation of HemeScreen,...
Enzo-logo-750-500.jpg
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
12 avr. 2022 08h30 HE | Enzo Biochem, Inc.
FOR IMMEDIATE RELEASE All Four Proposals Approved NEW YORK, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics...
Hardy Diagnostics Now Offers the BioCode® MDx-3000
14 mars 2022 07h00 HE | Hardy Diagnostics
SANTA MARIA, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics, a leader in manufactured and distributed microbiology products, is pleased to announce it is now the exclusive distributor...
PRPO logo.png
New York State Approves Precipio’s HemeScreen for POL clinical use
18 nov. 2021 10h00 HE | Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...
researchdrivelogo.jpg
Global Bloodstream Infection Testing Market Anticipated to Surpass $7,722.2 Million, Rising at 8.4% CAGR from 2019 to 2027 – Exclusive Report [247 Pages] By Research Dive
20 oct. 2021 09h10 HE | Research Dive
New York, USA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- A new report on the global bloodstream infection testing market has been added by Research Dive to its repository. According to the report, the...
PRPO logo.png
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
26 août 2021 10h00 HE | Precipio, Inc.
NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth...
researchdrivelogo.jpg
Increasing Cases of Coronavirus Infection around the World to Propel the Growth of Global COVID-19 Diagnostics Market – Exclusive Report [410 Pages] By Research Dive
18 août 2021 09h04 HE | Research Dive
New York, USA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global covid-19 diagnostics market is expected to generate a revenue of $65,750.1 million by...
researchdrivelogo.jpg
Rising Demand for Animal Testing Alternatives for Drug Testing to Boost the Growth of the Global Organ on Chip Market by 2028 – Exclusive Report [180 Pages] By Research Dive
18 août 2021 09h02 HE | Research Dive
New York, USA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- As per a latest report published by Research Dive, the global organ on chip market is estimated to register a revenue of $697,654.3 thousand by 2028,...